Use of Fibro Scan in Patients with Chronic Liver Disease
Portal hypertension is one of the important complications of Chronic Liver Disease and its early recognition is of paramount importance. Though liver biopsy remains the gold standard for diagnosing liver fibrosis and upper gastrointestinal (GI) endoscopy plays an important role in diagnosing different findings of portal hypertension, various noninvasive methods like FibroScan are being increasingly used nowadays to diagnose liver fibrosis. The study that I am talking about is published in the Journal of the Association of Physician of India (JAPI).
A total of 114 patients with Chronic Liver Disease and compensated cirrhosis were included in the study. All the patients underwent a detailed history and physical and gastrointestinal examination. Complete blood count (CBC), liver function test (LFT), kidney function test (KFT), and viral markers were done. Aspartate aminotransferase (AST) to platelet ratio index (APRI) score was calculated, liver fibrosis was estimated by FibroScan, and evidence of portal hypertension was documented by upper GI endoscopy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.